celecoxib has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pettersen, FO | 1 |
| Torheim, EA | 1 |
| Dahm, AE | 1 |
| Aaberge, IS | 1 |
| Lind, A | 1 |
| Holm, M | 1 |
| Aandahl, EM | 1 |
| Sandset, PM | 1 |
| Taskén, K | 1 |
| Kvale, D | 1 |
| Barreto-de-Souza, V | 1 |
| Pacheco, GJ | 1 |
| Silva, AR | 1 |
| Castro-Faria-Neto, HC | 1 |
| Bozza, PT | 1 |
| Saraiva, EM | 1 |
| Bou-Habib, DC | 1 |
1 trial available for celecoxib and HIV Coinfection
| Article | Year |
|---|---|
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.
Topics: Adult; AIDS Vaccines; Celecoxib; Chronic Disease; Cyclooxygenase 2 Inhibitors; Disease Progression; | 2011 |
1 other study available for celecoxib and HIV Coinfection
| Article | Year |
|---|---|
Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis.
Topics: Animals; Antibodies, Viral; Celecoxib; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase Inhibitors; | 2006 |